ESR1 and cancer: Noteworthy findings included genes associated with aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects and Estrogen‐dependent nuclear events downstream of ESR‐membrane signaling, hinting at intricate molecular mechanisms contributing to the therapeutic effects, as highlighted in Figure 2E.